Primary Neonatal Outcomes in metformin and MNT group in Early Trimester with Early GestationalGlucose Intolerance
Diabetes Asia Journal · 28.03.2026 · 3 (1) · 03-04
DOI: 10.62996/daj.73052025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Asia Journal, online erschienen am 28.03.2026. Verfasst von Shaily Agarwal und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Method
A study included pregnant women at 8 to 10 weeks of gestation, divided into two groups based on their blood sugar levels of≥110 mg/dl. Those with high levels ≥110 mg/dl received two different interventions: Metformin-MNT and MNT only. Follow-up outcomes were done until delivery.
Results
Primary Outcomes* The Adverse neonatal composite outcomes in the groups were 35 (37.6%) vs 55 (52.3), which were statistically significant (P = 0.038), but the Primary Maternal hypertension composite outcomes were not significant (9 (9.6%) vs 10 (10.7%), P = 0.80) (Table 1). IUD/Spontaneous abortion 8-28 Weeks and stillbirth are 20 (16) and 12(9.6) in the MNT Group compared to nil in the MNT-Metformin intervention group, which is highly significant.
Conclusion
It’s important to keep maternal 2-hour postprandial blood glucose (PPBG) levels below 110 mg/dL in the 10th week of pregnancy to prevent fetal hyperinsulinemia and improve maternal-fetal health.
Zitieren
APA
Agarwal, S., Tiwari, S., Verma, S., & Taneja, P. (2026). Primary Neonatal Outcomes in metformin and MNT group in Early Trimester with Early GestationalGlucose Intolerance. Diabetes Asia Journal, 3(1), 03-04. https://doi.org/10.62996/daj.73052025
Vancouver
Agarwal S, Tiwari S, Verma S, Taneja P. Primary Neonatal Outcomes in metformin and MNT group in Early Trimester with Early GestationalGlucose Intolerance. Diabetes Asia Journal. 2026;3(1):03-04. doi:10.62996/daj.73052025
BibTeX
@article{Agarwal2026,
author = {Agarwal, Shaily and Tiwari, Sadhana and Verma, Shweta and Taneja, Palak},
title = {Primary Neonatal Outcomes in metformin and MNT group in Early Trimester with Early GestationalGlucose Intolerance},
journal = {Diabetes Asia Journal},
year = {2026},
volume = {3},
number = {1},
pages = {03--04},
doi = {10.62996/daj.73052025}
}
EUVIMED